Expansion and Reorganization of the Existing Tariff Damage Support Center

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced that, starting March 6, they will operate the "Healthcare Industry Damage Support Center" to support domestic biohealth export companies and medical institutions expected to be affected by the worsening situation in the Middle East.


Ministry of Health and Welfare Sejong Government Complex. Photo by Yonhap News

Ministry of Health and Welfare Sejong Government Complex. Photo by Yonhap News

View original image

Since April 25 last year, the Ministry of Health and Welfare has operated the "Biohealth Industry Tariff Damage Support Center" within the Korea Health Industry Development Institute, a specialized agency for the health industry, to enhance the competitiveness of domestic biohealth companies and minimize damage caused by U.S. tariff measures.


Due to the recent deterioration of the situation in the Middle East, damage is expected for domestic biohealth export companies and medical institutions operating in the region. To minimize losses for Korean companies and provide swift support, the center will be expanded and operated as the "Healthcare Industry Damage Support Center."


The Damage Support Center will be operated in close collaboration with relevant ministries such as the Ministry of Trade, Industry and Energy and the Ministry of SMEs and Startups, as well as related organizations including the Korea International Trade Association, Korea Trade-Investment Promotion Agency (KOTRA), Korea Trade Insurance Corporation, and the Export-Import Bank of Korea.


Biohealth export companies and medical institutions facing difficulties due to the worsening situation in the Middle East can report cases of damage and challenges via the main email, telephone, or the Korea Health Industry Development Institute website to receive consultation and support.



Jung Eunyoung, Director General of the Health Industry Policy Bureau, stated, "We will continue to closely monitor the situation and challenges faced by our biohealth export companies and medical institutions operating in the Middle East through close cooperation with relevant ministries and organizations, and we will actively provide support to minimize the damage."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing